ShockWave Medical/SWAV

$327.65

0.04%
-
1D1W1MYTD1YMAX

About ShockWave Medical

Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.

Ticker

SWAV

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Douglas Godshall

Employees

1,468

Headquarters

Santa clara, United States

SWAV Metrics

BasicAdvanced
$12.28B
Market cap
84.87
P/E ratio
$3.86
EPS
0.88
Beta
-
Dividend rate
$12.28B
0.88062
$331.58
$157.00
1.01M
11.758
10.726
109.449
109.449
94.655
19.7%
13.31%
24.96%
14.4%
84.872
16.822
18.117
22.907
74.241
49.11%
-32.14%
120.85%

What the Analysts think about SWAV

Analyst Ratings

Majority rating from 11 analysts.
Hold

Price Targets

Average projection from 10 analysts.
3.51% downside
High $368.00
Low $210.00
$327.65
Current price
$316.14
Average price target

SWAV Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
21.83% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$202.9M
9.09%
Net income
$44.3M
26.93%
Profit margin
21.83%
16.36%

SWAV Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 30.54%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.03
$0.76
$0.92
$1.16
-
Expected
$0.81
$0.86
$0.79
$0.89
$0.98
Surprise
27.34%
-11.13%
15.92%
30.54%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for ShockWave Medical stock?

ShockWave Medical (SWAV) has a market cap of $12.28B as of April 20, 2024.

What is the P/E ratio for ShockWave Medical stock?

The price to earnings (P/E) ratio for ShockWave Medical (SWAV) stock is 84.87 as of April 20, 2024.

Does ShockWave Medical stock pay dividends?

No, ShockWave Medical (SWAV) stock does not pay dividends to its shareholders as of April 20, 2024.

When is the next ShockWave Medical dividend payment date?

ShockWave Medical (SWAV) stock does not pay dividends to its shareholders.

What is the beta indicator for ShockWave Medical?

ShockWave Medical (SWAV) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the ShockWave Medical stock price target?

The target price for ShockWave Medical (SWAV) stock is $316.14, which is 3.91% below the current price of $329. This is an average based on projections from 10 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell ShockWave Medical stock

Buy or sell ShockWave Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing